TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines (Publications)
Distinct immune responses are required for efficient elimination of different pathogens. Programming of the desired type of immune response by safe non-replicating vaccines requires suitable vaccine a
Antigenicity and immunogenicity of a novel <em>Plasmodium vivax</em> circumsporozoite derived synthetic vaccine construct (Publications)
BACKGROUND: The circumsporozoite (CS) protein is a major malaria sporozoite surface antigen currently being considered as vaccine candidate. Plasmodium vivax CS (PvCS) protein comprises a dimorphic ce
Evaluation of <em>in vitro</em> antiprotozoal activity of <em>Ajuga laxmannii </em>and its secondary metabolites (Publications)
Context Some Ajuga L. (Lamiaceae) species are traditionally used for the treatment of malaria, as well as fever, which is a common symptom of many parasitic diseases. Objective In the continuation of
Isolation of nontuberculous <em>Mycobacteria</em> from the environment of Buruli ulcer endemic communities in Ghana (Publications)
BACKGROUND: This study aimed to isolate nontuberculous mycobacterial species from environmental samples obtained from some selected communities in Ghana. METHODS: To optimise decontamination, spiked e
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks... (Publications)
BACKGROUND: The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable